Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The enzyme heme oxygenase-1 (HO-1) is a cytoprotective and anti-inflammatory protein that degrades heme to produce biliverdin/bilirubin, ferrous iron and carbon monoxide (CO). The anti-inflammatory properties of HO-1 are related to inhibition of adhesion molecule expression and reduction of oxidative stress, while exogenous CO gas treatment decreases the production of inflammatory mediators such as cytokines and nitric oxide (NO). CO-releasing molecules (CO-RMs) are a novel group of substances identified by our group that are capable of modulating physiological functions via the liberation of CO. We aimed in this study to examine the potential anti-inflammatory characteristics of CORM-2 and CORM-3 in an in vitro model of lipopolysaccharide (LPS)-stimulated murine macrophages. Stimulation of RAW264.7 macrophages with LPS resulted in increased expression of inducible NO synthase (iNOS) and production of nitrite. CORM-2 or CORM-3 (10-100 microM) reduced nitrite generation in a concentration-dependent manner but did not affect the protein levels of iNOS. CORM-3 also decreased nitrite levels when added 3 or 6 h after LPS exposure. CORM-2 or CORM-3 did not cause any evident cytotoxicity and produced an increase in HO-1 expression and heme oxygenase activity; this effect was completely prevented by the thiol donor N-acetylcysteine. CORM-3 also considerably reduced the levels of tumor necrosis factor-alpha, another mediator of the inflammatory response. The inhibitory effects of CORM-2 and CORM-3 were not observed when the inactive compounds, which do not release CO, were coincubated with LPS. These results indicate that CO liberated by CORM-2 and CORM-3 significantly suppresses the inflammatory response elicited by LPS in cultured macrophages and suggest that CO carriers can be used as an effective strategy to modulate inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations suggest that NF-κB is activated because of a lack of HO-1 derived anti-inflammatory molecules (CO, bilirubin) and is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα production (Sawle et al., 2005; Megias et al., 2007; Motterlini et al., 2012).”
From Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection: Heme oxygenase 1 expression affects Salmonella infection (2016) · cites this paper as Sawle et al., 2005
Citations
Cites
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Reduced stress defense in heme oxygenase 1-deficient cells
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10925 · Cited by 1,291
Stamler (2001) · doi:10.1016/s0092-8674(01)00495-0 · Cited by 1,261 · cited 2×
“…once CO is liberated, it will tightly bind to cellular targets that preserve CO bioactivity over time, in a manner similar to S-nitrosothiols, such as S-nitrosoalbumin and S-nitrosoglutathione (Stamler et al., 2001), which are long-lived species acting apparently as a reservoir of NO bioactivity.”
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency
Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Ohta, K., Kasahara, Y., & Koizumi, S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4165 · Cited by 1,255
Heme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019
Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998
Heme oxygenase: A novel target for the modulation of inflammatory response
Willis, D., Moore, A. R., Frederick, R., & Willoughby, D. A. (1996) · Nature Medicine · doi:10.1038/nm0196-87 · Cited by 783
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Research works printed but not linked: 1
- 10.1042/bj3480615 · doi:10.1042/bj3480615 · Paper page
Cited by
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
“Both CO gas and CO-RMs have potent anti-inflammatory effects as they are able to decrease the production of inflammatory mediators and to attenuate the levels of NO and tumour necrosis factor-α in macrophages stimulated with bacterial endotoxi”
BackgroundPharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
“Furthermore, HO-1/CO activation down-regulates the inflammatory response by blocking the release of NO from iNOS and expression of the granulocyte-macrophage colony-stimulating factor from macrophages and smooth muscle cells (Zhan et al., 2003; Sawle et al., 2005).”
Developing drug molecules for therapy with carbon monoxide
Romão, C. C., Blättler, W. A., Seixas, J. D., & Bernardes, G. J. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15317c · Cited by 524
Oh, G.-S., Pae, H.-O., Lee, B.-S., Kim, B.-N., Kim, J.-M., Kim, H.-R., Jeon, S. B., Jeon, W. K., Chae, H.-J., & Chung, H.-T. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.021 · Cited by 420
Heme Oxygenase-1 in Tumors: Is It a False Friend?
Jozkowicz, A., Was, H., & Dulak, J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1659 · Cited by 382
“Thus, in lipopolysaccharide (LPS)-stimulated macrophages, it decreased significantly the generation of inducible nitric oxide synthase (iNOS)-derived NO and production of TNF or IL-6 (123, 135).”
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
Ryter, S. W., & Choi, A. M. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.011 · Cited by 362
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Zuckerbraun, B. S., Chin, B. Y., Bilban, M., d'Avila, J. D. C., Rao, J., Billiar, T. R., & Otterbein, L. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-6644com · Cited by 323
Zheng, Y., Ji, X., Yu, B., Ji, K., Gallo, D., Csizmadia, E., Zhu, M., Choudhury, M. R., De La Cruz, L. K. C., Chittavong, V., et al. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0055-2 · Cited by 318
Therapeutic applications of carbon monoxide-releasing molecules
Motterlini, R., Mann, B. E., & Foresti, R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1305 · Cited by 315
“Because recently published reports demonstrated that CORM-3 induces HO-1 in vitro and in vivo [56,57], it is tempting to speculate that activation of the HO-1 pathway could contribute to the late-phase preconditioning effect, which is known to be characterised by the activation of inducible defensive proteins [58].”
BackgroundMancuso, C. (2007) · Frontiers in Bioscience · doi:10.2741/2130 · Cited by 294
“this gas is able to induce HO-1 protein (118) and acutely reduce the intracellular GSH content, allowed to hypothesize a prooxidant, other than antioxidant effect of this gas (Figure 4).”
BackgroundHeme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities
Loboda, A., Jazwa, A., Grochot-Przeczek, A., Rutkowski, A. J., Cisowski, J., Agarwal, A., Jozkowicz, A., & Dulak, J. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2043 · Cited by 265
“Similar results have been obtained by using CORM-2 and CORM-3, suggesting that CO carriers can be used as an effective strategy to modulate inflammation (369).”
Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice
Belcher, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26857 · Cited by 265
Heme oxygenase-1 in tumor biology and therapy
Was, H., Dulak, J., & Jozkowicz, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011551 · Cited by 259
“Thus, in lipopolysaccharide (LPS)-stimulated macrophages, it decreased the generation of inducible nitric oxide synthase (iNOS)-derived NO and production of TNF, IL-1β, MIP-1β, or IL-6 [61, 239], and these effects were exerted by interfering with AP-1 activity via a c-Jun N-terminal kinase (JNK) pathway [240].”
BackgroundMin, K.-J., Yang, M.-S., Kim, S.-U., Jou, I., & Joe, E.-H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-05.2006 · Cited by 257
“Similar results have been reported in macrophages, in which CORM treatment reduced NO production but not iNOS expression (Sawle et al., 2005).”
ResultUse of carbon monoxide as a therapeutic agent: promises and challenges
Foresti, R., Bani-Hani, M. G., & Motterlini, R. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1011-1 · Cited by 251
The roles of TNF in brain dysfunction and disease
Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 232
Carbon Monoxide-Releasing Micelles for Immunotherapy
Hasegawa, U., van der Vlies, A. J., Simeoni, E., Wandrey, C., & Hubbell, J. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1075025 · Cited by 224
Hoetzel, A., Dolinay, T., Schmidt, R., Choi, A. M. K., & Ryter, S. W. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1762 · Cited by 219
“:3) production were also demonstrated with the application of CORM ( e.g ., CORM-2) (112).”
Heme Oxygenase-1 as a Potential Therapeutic Target for Hepatoprotection
Farombi, E. O., & Surh, Y.-J. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.479 · Cited by 215
“7 murine macrophages (Sawle et al., 2005) and also in rat liver via modulation of iNOS expression and NO production (Sarady et al.”
BackgroundNIR‐Responsive On‐Demand Release of CO from Metal Carbonyl‐Caged Graphene Oxide Nanomedicine
He, Q., Kiesewetter, D. O., Qu, Y., Fu, X., Fan, J., Huang, P., Liu, Y., Zhu, G., Liu, Y., Qian, Z., et al. (2015) · Advanced Materials · doi:10.1002/adma.201502762 · Cited by 211
Overexpression of Heme Oxygenase-1 in Murine Melanoma
Was, H., Cichon, T., Smolarczyk, R., Rudnicka, D., Stopa, M., Chevalier, C., Leger, J. J., Lackowska, B., Grochot, A., Bojkowska, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051365 · Cited by 192
“For example, exposure of macrophages to CO can result in decreased synthesis of cytokines, including TNF.75 Accordingly, our study demonstrates that overexpression of HO-1 in melanoma cells inhibits production of TNF by the tumor-bearing mice.”
BackgroundInfluentialWang, X., Wang, Y., Kim, H. P., Nakahira, K., Ryter, S. W., & Choi, A. M. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607610200 · Cited by 192
RetractedLancel, S., Hassoun, S. M., Favory, R., Decoster, B., Motterlini, R., & Neviere, R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.148049 · Cited by 191
“…those demonstrating that CO affords protection against endotoxin challenge in vitro and in vivo by inhibiting of proinflammatory cytokine production such as TNF- and IL-1 , in a mechanism involving the modulation of p38 mitogen-activated protein kinase (Otterbein et al., 2000; Sawle et al., 2005).”
BackgroundInfluentialTsoyi, K., Lee, T. Y., Lee, Y. S., Kim, H. J., Seo, H. G., Lee, J. H., & Chang, K. C. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055137 · Cited by 190
“Although it has been reported that CORMs significantly suppressed the inflammatory response elicited by LPS in cultured macrophages (Sawle et al., 2005), there was no report about the effect of CORMs on HMGB1 release.”
BackgroundLi, H., Kim, H., Han, J., Nguyen, V., Peng, X., & Yoon, J. (2021) · Aggregate · doi:10.1002/agt2.51 · Cited by 189
Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes
Alberto, R., & Motterlini, R. (2007) · Dalton Transactions · doi:10.1039/b701992k · Cited by 182
Foresti, R., Bains, S. K., Pitchumony, T. S., de Castro Brás, L. E., Drago, F., Dubois-Randé, J.-L., Bucolo, C., & Motterlini, R. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.07.010 · Cited by 176
Motterlini, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351142 · Cited by 173
Mann, B. E., & Motterlini, R. (2007) · Chemical Communications · doi:10.1039/b704873d · Cited by 172
Davidge, K. S., Sanguinetti, G., Yee, C. H., Cox, A. G., McLeod, C. W., Monk, C. E., Mann, B. E., Motterlini, R., & Poole, R. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808210200 · Cited by 162
[Mn(CO)4{S2CNMe(CH2CO2H)}], a new water-soluble CO-releasing molecule
Crook, S. H., Mann, B. E., Meijer, A. J. H. M., Adams, H., Sawle, P., Scapens, D., & Motterlini, R. (2011) · Dalton Transactions · doi:10.1039/c1dt10125k · Cited by 158
Lo Iacono, L., Boczkowski, J., Zini, R., Salouage, I., Berdeaux, A., Motterlini, R., & Morin, D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.033 · Cited by 160
“[Ru(CO)3Cl(glycinate)] (CORM-3) and its inactive counterpart [Ru(DMSO)4Cl2] (iCORM-3) were synthesized as previously described [11].”
BackgroundMethodYang, G., Fan, M., Zhu, J., Chen, L., Wu, L., Zhang, X., Zhang, M., Li, J., Yao, Q., Gu, Z., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120155 · Cited by 158
Harnessing carbon monoxide-releasing platforms for cancer therapy
Zhou, Y., Yu, W., Cao, J., & Gao, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120193 · Cited by 149
Carbon monoxide: Mechanisms of action and potential clinical implications
Rochette, L., Cottin, Y., Zeller, M., & Vergely, C. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.007 · Cited by 163
Role of carbon monxide in cardiovascular function
Durante, W., Johnson, F. K., & Johnson, R. A. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00427.x · Cited by 144
Spontaneous CO Release from RuII(CO)2–Protein Complexes in Aqueous Solution, Cells, and Mice
Chaves‐Ferreira, M., Albuquerque, I. S., Matak‐Vinković, D., Coelho, A. C., Carvalho, S. M., Saraiva, L. M., Romão, C. C., & Bernardes, G. J. L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409344 · Cited by 144
Protective effect of carbon monoxide in transplantation
Nakao, A., Choi, A. M. K., & Murase, N. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00426.x · Cited by 151
Cepinskas, G., Katada, K., Bihari, A., & Potter, R. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00348.2007 · Cited by 146
Carbon monoxide in lung cell physiology and disease
Ryter, S. W., Ma, K. C., & Choi, A. M. K. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00022.2017 · Cited by 135
“Similar to gaseous CO, CORMs have demonstrated vasoactive effects (47), as well as anti-inflammatory effects in various injury and disease models (22, 82, 83, 140, 159).”
BackgroundSrisook, K., Han, S.-S., Choi, H.-S., Li, M., UEDA, H. M. D., Kim, C., & Cha, Y. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.042 · Cited by 143
Попова, М., Lazarus, L. S., Ayad, S., Benninghoff, A. D., & Berreau, L. M. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b06011 · Cited by 134
“With this data in hand, we examined how effectively the compounds could attenuate LPS-induced inflammation by suppressing production of TNF-α.46 Two plates of RAW 264.7 cells were pretreated with 1-3 for 4 h in the presence of 0.6 mM BSA followed by illumination of one of the plates using a blue LED array (66451 lx) f…”
InfluentialTreatment with CO-RMs during cold storage improves renal function at reperfusion
Sandouka, A., Fuller, B. J., MANN, B. E., Green, C. J., Foresti, R., & Motterlini, R. (2006) · Kidney International · doi:10.1038/sj.ki.5000016 · Cited by 148
Therapeutic Antioxidant Medical Gas
Nakao, A., Sugimoto, R., Billiar, T. R., & McCurry, K. R. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-193r · Cited by 135
Carbon monoxide in exhaled breath testing and therapeutics
Ryter, S. W., & Choi, A. M. K. (2013) · Journal of Breath Research · doi:10.1088/1752-7155/7/1/017111 · Cited by 143
“CORMs reduce cytokine release in LPS-stimulated macrophages [178], and decrease inflammatory responses and oxidative stress in LPS-stimulated endothelial cells [179].”
BackgroundDe Backer, O., Elinck, E., Blanckaert, B., Leybaert, L., Motterlini, R., & Lefebvre, R. A. (2009) · Gut · doi:10.1136/gut.2008.155481 · Cited by 123
Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule
Tayem, Y. I., Johnson, T. R., Mann, B. E., Green, C. J., & Motterlini, R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00363.2005 · Cited by 122
“Of particular interest is that CORM-3, a water-soluble ruthenium carbonyl complex, has been demonstrated to protect against myocardial ischemia-reperfusion injury (9), heart graft rejection (9), vasoconstriction (11), and inflammatory reactions (28).”
BackgroundInfluentialCarbon Monoxide: An Essential Signalling Molecule
Mann, B. E. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_10 · Cited by 124
Desmard, M., Foresti, R., Morin, D., Dagouassat, M., Berdeaux, A., Denamur, É., Crook, S. H., Mann, B. E., Scapens, D., Montravers, P., et al. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3959 · Cited by 121
Carbon Monoxide Inhibits TLR-Induced Dendritic Cell Immunogenicity
Rémy, S., Blancou, P., Tesson, L., Tardif, V., Brion, R., Royer, P. J., Motterlini, R., Foresti, R., Painchaut, M., Pogu, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802436 · Cited by 120
Li, X., Wu, L., Liu, W., Jin, Y., Chen, Q., Wang, L., Fan, X., Li, Z., & Cheng, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095004 · Cited by 137
“Carbon monoxide (CO) was proposed to be involved in the protective effects of HO-1, including its anti-inflammatory actions [80,81].”
BackgroundGao, L., Cheng, J., Shen, Z., Zhang, G., Liu, S., & Hu, J. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202112782 · Cited by 120
Balan, I. S., Beattie, M. C., O’Buckley, T. K., Aurelian, L., & Morrow, A. L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37409-6 · Cited by 130
Megías, J., Busserolles, J., & Alcaraz, M. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707184 · Cited by 117
“As CO and CORM-2 may induce HO-1 (Sawle et al., 2005), which could inhibit NO production (Turcanu et al., 1998), we assessed the effect of CORM-2 on HO-1 protein expression.”
BackgroundInfluentialTargeting Heme Oxygenase-1 in Vascular Disease
Durante, W. (2010) · Current Drug Targets · doi:10.2174/1389450111009011504 · Cited by 121
“Furthermore, CO downregulates the inflammatory response by blocking inducible NO synthase activity and the expression of granulocyte-macrophage colony stimulating factor, which is known to promote the production of inflammatory mediators and the differentiation of hematopoietic progenitor cells into macrophages and ne…”
BackgroundBasuroy, S., Bhattacharya, S., Tcheranova, D., Qu, Y., Regan, R. F., Leffler, C. W., & Parfenova, H. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00032.2006 · Cited by 112
“Recent papers present experimental evidence that CO and CO-releasing molecules do inhibit mitochondrial function and ROS generation (16, 30, 54, 55, 58, 59).”
BackgroundChłopicki, S., Olszanecki, R., Marcinkiewicz, E., Łomnicka, M., & Motterlini, R. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.011 · Cited by 115
“One of these compounds, CORM-3 ((tricarbonylchloro(glycinato)ruthenium(II)) has a unique feature of being fully water-soluble and has been shown to simulate the bioactivities of gaseous CO including vessel relaxation [23,24], protection against ischemia–reperfusion injury [23,25,26], prevention of organ rejection foll…”
BackgroundJackson, C. S., Schmitt, S. M., Dou, Q. P., & Kodanko, J. J. (2011) · Inorganic Chemistry · doi:10.1021/ic200676s · Cited by 119
Wei, Y., Chen, P., de Bruyn, M., Zhang, W., Bremer, E., & Helfrich, W. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-42 · Cited by 110
Yin, H., Fang, J. Q., Liao, L., Nakamura, H., & Maeda, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.018 · Cited by 105
Carbon monoxide: present and future indications for a medical gas
Ryter, S. W., & Choi, A. M. K. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.2.123 · Cited by 109
“CORMs have been shown to inhibit proinf lammatory cytokine production in LPS-stimulated macrophages [162], and decrease the inflammatory response and oxidative stress in LPS-stimulated endothelial cells [163].”
BackgroundThe Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Mancuso, C., & Barone, E. (2009) · Current Drug Metabolism · doi:10.2174/138920009789375405 · Cited by 98
“The fact that CO exposure causes overproduction of mitochondrial ROS, induction of HO-1 protein expression [93], and acute reductions in the intracellular GSH content suggests that, although it is clearly capable of producing antioxidant effects, CO is first and foremost a pro-oxidant (Fig.”
BackgroundPi, J., Li, T., Liu, J., Su, X., Wang, R., Yang, F., Bai, H., Jin, H., & Cai, J. (2014) · Micron · doi:10.1016/j.micron.2014.03.012 · Cited by 115
“7 macrophage model (Nishida et al., 2010; i et al., 2012; Sawle et al., 2005; Hwang et al., 2001), we also hoose 100 ng/mL and 1 g/mL LPS to activate RAW264.”
MethodFerrándiz, M. L., Maicas, N., García-Arnandis, I., Terencio, M. C., Motterlini, R., Devesa, I., Joosten, L. A. B., van den Berg, W. B., & Alcaraz, M. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082412 · Cited by 105
Marhenke, J., Trevino, K. M., & Works, C. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.02.017 · Cited by 95
Lin, H.-Y., Shen, S., Lin, C., Yang, L., & Chen, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.04.008 · Cited by 96
Xue, C., Tian, J., Cui, Z., Liu, Y., Sun, D., Xiong, M., Yi, N., Wang, K., Li, X., Wang, Y., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.032 · Cited by 90
“7 cells in a created environment with overexpressed ROS [33].”
BackgroundCarbon Monoxide-Releasing Molecules Modulate Leukocyte-Endothelial Interactions under Flow
Urquhart, P., Rosignoli, G., Cooper, D., Motterlini, R., & Perretti, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117218 · Cited by 90
“A few studies using CO-RMs as a way to unveil the biological functions of CO have now been published, demonstrating the validity of these compounds to investigate the mechanisms of action of this elusive short-lived gas (Motterlini et al., 2005; Sawle et al., 2005; Stein et al., 2005; Chlopicki et al., 2006).”
BackgroundSeta, F., Bellner, L., Rezzani, R., Regan, R. F., Dunn, M. W., Abraham, N. G., Gronert, K., & Schwartzman, M. L. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060555 · Cited by 97
Click chemistry and drug delivery: A bird's-eye view
Kondengadan, S. M., Bansal, S., Yang, C., Liu, D.-N., Fultz, Z., & Wang, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.015 · Cited by 97
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs)
Motterlini, R., Haas, B., & Foresti, R. (2012) · Medical Gas Research · doi:10.1186/2045-9912-2-28 · Cited by 86
Therapeutic Aspects of Carbon Monoxide in Cardiovascular Disease
Kim, H.-H., & Choi, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082381 · Cited by 93
“One of the possible mechanisms for the CO-mediated inhibition of inflammation is via the suppression of the production and release of TNF-α in lipopolysaccharide (LPS)-stimulated macrophages [57].”
BackgroundAdvances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
Liu, D., Zeng, X., Li, X., Cui, C., Hou, R., Guo, Z., Mehta, J. L., & Wang, X. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113863 · Cited by 92
Zhang, W., Atkin, A. J., Thatcher, R. J., Whitwood, A. C., Fairlamb, I. J. S., & Lynam, J. M. (2009) · Dalton Transactions · doi:10.1039/b822157j · Cited by 87
Heme Oxygenase, Inflammation, and Fibrosis: The Good, the Bad, and the Ugly?
Lundvig, D. M. S., Immenschuh, S., & Wagener, F. A. D. T. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00081 · Cited by 85
“The CO-RMs have been demonstrated to provide cytoprotective effects in different in vitro (Clark et al., 2003; Sandouka et al., 2005; Sawle et al., 2005; Srisook et al., 2006; Zobi et al., 2010) and in vivo (Vera et al., 2005; Sandouka et al., 2006; Zhou et al., 2009; Wei et al., 2010) models,…”
Nguyen, D., & Boyer, C. A. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00230 · Cited by 88
Banihani, M., Greenstein, D., Mann, B. E., Green, C. J., & Motterlini, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104729 · Cited by 86
“In fact, HO-1 induction has been demonstrated to protect against such injuries in almost all cell types including cardiomyocytes (Clark et al., 2003), hepatocytes (Amersi et al., 1999), lung tissue (Minamino et al., 2001), and neuronal tissue (Panahian et al., 1999).”
BackgroundMethodResultInfluentialTomiyama, K., Ikeda, A., Ueki, S., Nakao, A., Stolz, D. B., Koike, Y., Afrazi, A., Gandhi, C. R., Tokita, D., Geller, D. A., et al. (2008) · Hepatology · doi:10.1002/hep.22482 · Cited by 85
Protective role of heme oxygenase-1 against inflammation in atherosclerosis
Durante, W. (2011) · Frontiers in bioscience · doi:10.2741/3860 · Cited by 85
“Deletion of HO-1 also results in the greater release of IL-6 and CCL2 from activated macrophages while overexpression of HO-1 decreases the synthesis of several pro-inflammatory cytokines, including IL-6, CCL2, and TNFα (64-66).”
BackgroundInfluentialLi, X., Wang, X., Liu, Q., Yan, J., Pan, D., Wang, L., Xu, Y., Wang, F., Liu, Y., Li, X., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100883 · Cited by 88
Atkin, A. J., Williams, S., Sawle, P., Motterlini, R., Lynam, J. M., & Fairlamb, I. J. S. (2009) · Dalton Transactions · doi:10.1039/b904627p · Cited by 83
Katada, K., Bihari, A., Mizuguchi, S., Yoshida, N., Yoshikawa, T., Fraser, D. D., Potter, R. F., & Cepinskas, G. (2009) · Inflammation · doi:10.1007/s10753-009-9162-y · Cited by 84
“In addition, anti-inflammatory activity of CORM-2, a DMSO-soluble CORM, has also been demonstrated in an in vitro model of inflammation employing LPS-stimulated human-derived vascular endothelial cells (HUVEC) [23], human PMN [26] or murine macrophages [25].”
BackgroundInfluentialBioactive Properties of Iron-Containing Carbon Monoxide-Releasing Molecules
Sawle, P., Hammad, J., Fairlamb, I. J. S., Moulton, B. E., O'Brien, C. T., Lynam, J. M., Duhme‐Klair, A., Foresti, R., & Motterlini, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101758 · Cited by 83
“After incubation, nitrite levels were determined using the Griess method as described previously by our group (Sawle et al., 2005).”
BackgroundMethodInfluentialChoi, H.-G., Lee, D., Li, B., Choi, Y. H., Lee, S., & Kim, Y. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.04.016 · Cited by 86
Group 6 Carbon Monoxide-Releasing Metal Complexes with Biologically-Compatible Leaving Groups
Zhang, W., Whitwood, A. C., Fairlamb, I. J. S., & Lynam, J. M. (2010) · Inorganic Chemistry · doi:10.1021/ic101230j · Cited by 82
Breathing Micelles for Combinatorial Treatment of Rheumatoid Arthritis
Tao, S., Cheng, J., Su, G., Li, D., Shen, Z., Tao, F., You, T., & Hu, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010009 · Cited by 80
Hervera, A., Leánez, S., Negrete, R., Motterlini, R., & Pol, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043693 · Cited by 80
“Carbon monoxide-releasing molecules (CO-RMs) are a new class of chemical agents able to reproduce numerous biological effects of HO-1-derived CO [20–23].”
BackgroundWang, P., Huang, J., Li, Y., Chang, R., Wu, H., Lin, J., & Huang, Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160920595 · Cited by 79
“CO-releasing molecules (CORMs) and as therapeutic agents aimed at delivering controlled amounts of CO to tissues and organs [11,12].”
BackgroundTargeting Heme Oxygenase: Therapeutic Implications for Diseases of the Cardiovascular System
Peterson, S. J., Frishman, W. H., & Abraham, N. G. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e31819d813a · Cited by 88
“CO and NO are capable of inducing the relaxation of blood vessels through vasodilation and inhibiting the proliferation of VSMC.82 Like NO, HOderived CO influences the sGC and cyclic guanosine monophosphate (cGMP) pathways, which serve to regulate both blood pressure and vascular contractility.83 sGC increases cGMP, w…”
BackgroundInfluentialFaleo, G., Neto, J. S., Kohmoto, J., Tomiyama, K., Shimizu, H., Takahashi, T., Wang, Y., Sugimoto, R., Choi, A. M. K., Stolz, D. B., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e31817c6f63 · Cited by 82
Hervera, A., Leánez, S., Motterlini, R., & Pol, O. (2013) · Anesthesiology · doi:10.1097/aln.0b013e318286d085 · Cited by 81
Arqoub, H. A., Foresti, R., Green, C. J., & Motterlini, R. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00380.2005 · Cited by 81
“In addition, we have recently investigated the anti-inflammatory characteristics of CO-releasing molecules (CORM-2 and CORM-3) in macrophages stimulated with LPS and found that CO liberated by these agents significantly reduced nitrite production (34); similar results on nitrite and TNF- release were obtained also wit…”
BackgroundMethodResultInfluentialCarbon monoxide–based therapy ameliorates acute pancreatitis via TLR4 inhibition
Xue, J., & Habtezion, A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71362 · Cited by 78
“bubbling with air (N2) to remove residual CO (47).”
BackgroundIntegrative Survival Response Evoked by Heme Oxygenase-1 and Heme Metabolites
Pae, H., Kim, E.-C., & Chung, H. (2008) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2008029 · Cited by 80
“Sawle and coworkers [41] originally demonstrated that a CO-releasing molecule (CORM) increased HO-1 expression and HO activity.”
BackgroundSeixas, J., Mukhopadhyay, A., Santos-Silva, T., Otterbein, L., Gallo, D. J., Rodrigues, S. S., Guerreiro, B., Gonçalves, A. M. L., Penacho, N., Marques, A., et al. (2013) · Dalton Transactions · doi:10.1039/c2dt32174b · Cited by 55
Carbon monoxide reverses the metabolic adaptation of microglia cells to an inflammatory stimulus
Wilson, J. L., Bouillaud, F., Almeida, A. S., Vieira, H. L. A., Ouidja, M. O., Dubois‐Randé, J., Foresti, R., & Motterlini, R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.022 · Cited by 82
Kim, H., So, H., Lee, J., Lee, J., Park, C., Park, S.-Y., Kim, Y., Youn, M., Kim, S.-J., Chung, S.-Y., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.018 · Cited by 78
Chung, H., Choi, B.-M., Kwon, Y., & Kim, Y. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01218-4 · Cited by 77
Metadata
- Authors
- Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R.
- Affiliations
- Northwick Park Institute for Medical Research (GB)
- University of Sheffield (GB)
- Corresponding author
- Motterlini, Roberto
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 145
- Issue
- 6
- Pages
- 800-810
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1576195
- OpenAlex
- W2094470927
- Cited by
- 391
- References
- 36
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 16 · 2021: 22 · 2020: 16 · 2019: 10 · 2018: 18 · 2017: 14 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 25
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation
- Dunhill Medical Trust
- Engineering and Physical Sciences Research Council (GR/S30924/01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- carbon monoxide-releasing molecules, CORM-2, CORM-3, carbon monoxide, heme oxygenase-1, lipopolysaccharide, macrophages, RAW 264.7 macrophages, nitric oxide, inducible nitric oxide synthase, TNF-α, inflammation, anti-inflammatory activity, N-acetylcysteine
- MeSH terms
- Animals, Carbon Monoxide, Cell Line, Cell Survival, Glutathione, Heme Oxygenase (Decyclizing), Inflammation, Lipopolysaccharides, Macrophages, Membrane Proteins, Nitrites, Organometallic Compounds, Tumor Necrosis Factor-alpha, Nitric Oxide Synthase, Mice, Heme Oxygenase-1, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.